sábado, 13 de marzo de 2021

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply - The Lancet Rheumatology

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario